Skip to main content

Kumar Neil

In the past year, 15 open-market sale filings worth $61.5M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$61.5M
15 filings
Net
−$61.5M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Kumar Neil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BBIO BridgeBio Pharma, Inc.

Chief Executive Officer40 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2022 (view filing)Nov 171 dayKumar NeilCEO and PresidentSSale−34.6K$9.40−$325.6K−0.7%4.81M after
Dec 21, 2022 (view filing)Dec 21Same dayKumar NeilCEO and PresidentSSale−200.0K––−16.7%995.7K after
Jan 6, 2023 (view filing)Jan 51 dayKumar NeilCEO and PresidentSSale−120.0K$7.67−$920.4K−7.4%1.49M after
Feb 6, 2023 (view filing)Feb 33 daysKumar NeilCEO and PresidentSSale−120.0K$11.01−$1.32M−8.0%1.37M after
Feb 21, 2023 (view filing)Feb 174 daysKumar NeilCEO and PresidentSSale−44.8K$12.70−$568.9K−0.9%4.81M after
Mar 3, 2023 (view filing)Mar 3Same dayKumar NeilCEO and PresidentSSale−120.0K$10.96−$1.32M−8.7%1.25M after
Apr 7, 2023 (view filing)Apr 52 daysKumar NeilCEO and PresidentSSale−120.0K$15.46−$1.86M−9.6%1.13M after10b5-1
May 5, 2023 (view filing)May 32 daysKumar NeilCEO and PresidentSSale−120.0K$14.18−$1.70M−10.6%1.01M after10b5-1
May 18, 2023 (view filing)May 171 dayKumar NeilCEO and PresidentSSale−51.6K$14.01−$722.2K−1.1%4.81M after10b5-1
Aug 18, 2023 (view filing)Aug 171 dayKumar NeilCEO and PresidentSSale−51.6K$28.59−$1.47M−1.1%4.81M after10b5-1

See all 40 trades at BBIO